UNSPSC 41131619: Potentiating media for in vitro diagnostic use

In this classification, potentiating media for in vitro diagnostic use are media, such as bovine albumin, that are used to suspend red cells and to enhance cell reactions for antigen-antibody testing. US FDA regulates Potentiating media for in vitro diagnostic use under 21 CFR 864.96 and under FDA product code KSG.

UNSPSC 41131619 Potentiating media for in vitro diagnostic use is a Commodity code that sees minimal recent state and local procurement activity aligned with its nominal scope. The three most recent opportunities posted under this code—a janitorial and operational supplies bid from Hillsborough County (Florida), a Career Technical Education and Advanced Academics RFP from Klein Independent School District (Texas), and an emergency refrigerated truck rental RFQ from the City of Tucson (Arizona)—are plainly unrelated to laboratory media or diagnostic supplies. State and local procurement systems appear to have tagged these opportunities with the code incorrectly, indicating a fundamental mismatch between the code's intended commodity and actual buying activity in the public sector.

No recent state or local solicitations for potentiating media or in vitro diagnostic products are present in the available data. The code does not show actionable procurement momentum at present, and firms pursuing this space should rely on direct outreach to state health departments, public health laboratories, and hospital procurement offices rather than monitoring this UNSPSC category for relevant RFPs or RFQs.